Tube Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Tube Pharmaceuticals General Information

Description

Developer of toxic payloads designed for antibody-drug conjugates. The company specializes in the synthesis of cytolysin payloads and tumor microenvironment targeting technology, enabling biotechnology companies to develop oncology treatments that achieve tumor regression through targeted drug delivery.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Leberstrasse 20
  • Vienna, 1110
  • Austria
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Leberstrasse 20
  • Vienna, 1110
  • Austria

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tube Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tube Pharmaceuticals‘s full profile, request access.

Request a free trial

Tube Pharmaceuticals Patents

Tube Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018346395-A1 Oral bendamustine formulations Inactive 05-Oct-2017
CA-3078290-A1 Oral bendamustine formulations Pending 05-Oct-2017
EP-3691637-A1 Oral bendamustine formulations Inactive 05-Oct-2017
US-20200246312-A1 Oral bendamustine formulations Inactive 05-Oct-2017
US-20240390331-A1 Oral bendamustine formulations Inactive 05-Oct-2017 A61K31/4184
To view Tube Pharmaceuticals’s complete patent history, request access »

Tube Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tube Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tube Pharmaceuticals‘s full profile, request access.

Request a free trial

Tube Pharmaceuticals FAQs

  • When was Tube Pharmaceuticals founded?

    Tube Pharmaceuticals was founded in 2011.

  • Where is Tube Pharmaceuticals headquartered?

    Tube Pharmaceuticals is headquartered in Vienna, Austria.

  • What is the size of Tube Pharmaceuticals?

    Tube Pharmaceuticals has 1 total employees.

  • What industry is Tube Pharmaceuticals in?

    Tube Pharmaceuticals’s primary industry is Biotechnology.

  • Is Tube Pharmaceuticals a private or public company?

    Tube Pharmaceuticals is a Private company.

  • What is Tube Pharmaceuticals’s current revenue?

    The current revenue for Tube Pharmaceuticals is .

  • Who are Tube Pharmaceuticals’s investors?

    Ascenion has invested in Tube Pharmaceuticals.

  • When was Tube Pharmaceuticals acquired?

    Tube Pharmaceuticals was acquired on 08-Mar-2023.

  • Who acquired Tube Pharmaceuticals?

    Tube Pharmaceuticals was acquired by Oncomatryx Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process